HPV vaccination practices and attitudes among primary care physicians since FDA approval to age 45

Association between patient characteristics and HPV vaccination recommendation for postpartum patients: A national survey of Obstetrician/Gynecologists

“…As in previous research ( Petrusek et al, 2020 ), our results demonstrate an increase in recommendation likelihood in the 23-year-old age patient group compared to those in the 33-year-old age group. This difference may be due to current ACIP guidelines, where 23-year-olds, but not 33-year-olds, fall into the routine catch-up age group for HPV vaccination ( Meites et al, 2019 ).…”

Oral and periodontal manifestation related during human papilloma virus infections: Update on early prognostic factors

“…There are different formulations for the HPV vaccines: two-valent, four-valent, and nine-valent vaccines and there are also laws regulating their obligatory or recommendatory administration around the world, especially for the adolescents. For example, according to the US Food and Drug Administration (FDA) it recommended to vaccinate girls aged between 12 and 26 years and boys aged between 13 and 21 years old [ 175 ]. In addition, the FDA introduced the administration of nine-valent vaccine for women and men from 27 to 45 years old too [ 114 ].…”

Clinical and Public Health Considerations for HPV Vaccination in Midadulthood: A Narrative Review

“…A survey of obstetricians and gynecologists found that 94% were aware of the SCDM recommendation and 55% routinely recommended HPV vaccination to midadult patients [ 72 ]. A third study found that clinicians were more likely to recommend HPV vaccination to midadult females (26%) compared with males (17%) [ 73 ]. As the incidence of HPV-associated diseases, such as oropharyngeal cancer, rises among males, SCDM for midadult vaccination with all patients is important.…”